Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who do not have colitis, cancer, or significant polyps (meaning fewer than 3 polyps, all smaller than 1cm, and no high-risk polyp types) — this group acts as a comparison group
- People who have Inflammatory Bowel Disease (IBD, a condition causing chronic gut inflammation) and have never been treated with a specific type of medication called a TNF-α inhibitor
- People who have Inflammatory Bowel Disease (IBD) and are currently being treated with a TNF-α inhibitor medication (confirm with trial site for specific medication names)
Who may not be able to join:
- Anyone under 18 years of age
- Anyone who has taken antibiotics or probiotic supplements within the last 3 months before joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nayoung Kim, M.D., Ph.D, Seoul National University Bundang Hospital
Phone: + 82-31-787-7845
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The expression level of multiple markers associated with IBD activity or prognosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.